Ensysce Biosciences closes $1.1M registered direct offering and private placement of warrants

Ensysce Biosciences, Inc.

Gross proceeds of approximately $1.1M from sale of 315,188 shares (or equivalents) at $3.49/share.
Concurrent private placement: Series A-5 warrants (18-month term) and Series A-6 warrants (5-year term), each exercisable at $3.24/share.
Net proceeds of ~$0.9M to fund TAAP and MPAR program development and working capital.
H.C. Wainwright acted as exclusive placement agent; placement agent warrants for 22,063 shares at $4.3625/share.
30-day lock-up on further equity issuance and insider sales; beneficial ownership limitation of 4.99% (or 9.99%) on warrant exercise.

item 1.01 item 3.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001641172-25-001751
form_type: 8-K
ticker: ENSC
cik: 0001716947
company_name: Ensysce Biosciences, Inc.
filed_at: 2025-03-31T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.570960+00:00
generated_at: 2026-05-24T01:57:10.690719+00:00
sec_items: ["1.01", "3.02", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001641172-25-001751
json_url: https://secwatch.observer/filing/0001641172-25-001751.json
markdown_url: https://secwatch.observer/filing/0001641172-25-001751.md
text_url: https://secwatch.observer/filing/0001641172-25-001751.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1716947/000164117225001751/0001641172-25-001751-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1716947/000164117225001751/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001641172-25-001751

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.